BioNTech SE / Fundamentals
Income statement
- Net revenue
€2.86B - Cost of goods sold
€580.21M - Gross profit
€2.28B - SG&A expenses
€540.60M - R&D expenses
€2.19B - EBITDA
-€25.11M - D&A
€303.60M - EBIT
-€876.10M - Interest expenses
€45.30M - EBT
-€390.32M - Tax expenses
-€42.87M - Net income
-€347.44M
Cash flow statement
- Net deferred tax
-€6.78M - Non-cash items
-€507.06M - Changes in working capital
-€1.25B - Operating cash flow
-€1.72B - Capex
€821.02M - Other investing cash flow
-€549.38M - Net investing cash flow
€1.69B - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€27.12M - Other financing cash flow
-€15.18M - Net financing cash flow
-€42.30M - Foreign exchange effects
€21.49M - Net change in cash
-€107.20M - Cash at end of period
€10.27B - Free cash flow
-€894.26M
Balance sheet
- Cash and cash equivalents
€10.27B - Cash and short-term investments
€14.04B - Total receivables
€1.45B - Inventory
€230.70M - Other current assets
€215.00M - Total current assets
€15.93B - Property, plant & equipment
€1.24B - Goodwill
€364.10M - Intangible assets
€1.49B - Long-term investments
€2.50B - Other non-current assets
€32.70M - Total non-current assets
€5.71B - Total assets
€21.64B - Accounts payable
€504.20M - Short-term debt
€52.40M - Other current liabilities
€345.10M - Total current liabilities
€1.85B - Long-term debt
€217.20M - Deferred tax liabilities
€28.50M - Other non-current liabilities
€248.30M - Total non-current liabilities
€1.28B - Total liabilities
€3.13B - Common stock
€248.60M - Retained earnings
€18.30B - Other equity
-€1.48B - Total equity
€18.51B - Total liabilities and shareholders' equity
€21.64B
Company information
- Market capitalization
€21.88B - Employees
6.8K - Enterprise Value
€12.22B
Company ratios
- Gross margin
-
79.7% Much worse than peer group: 13,081,545,944,017,853,000.0% - EBITDA margin
-
-0.9% Much worse than peer group: 1,263,108,758,839,091,600.0% - EBIT margin
-
-30.6% Much worse than peer group: 1,083,070,293,407,367,400.0% - EBT margin
-
-13.6% Much worse than peer group: 1,323,572,561,325,365,200.0% - Net margin
-
-12.1% Much worse than peer group: 1,323,572,561,325,365,800.0% - ROE
-
-1.9% Much better than peer group: -409.0% - ROA
-
-1.6% Much better than peer group: -562.0% - Asset turnover
-
13.2% Worse than peer group: 18.3% - FCF margin
-
-88.6% Much worse than peer group: 749,793,453,164,235,800.0% - FCF yield
-11.6% - Efficiency ratio
100.9% - Net sales per employee
-
€422.59K - Net income per employee
-
-€51.31K